The group owns modern, sophisticated industrial plants at which it manufactures its proprietary drugs to the highest quality standards. The first plant, at which injectables and solid oral drugs are manufactured, is situated in Milan, and a second manufacturing unit, for the production of liquid oral drugs, is located in Madrid.

The Italfarmaco Group is particularly active in the field of research, mainly oriented towards the cardiovascular area and diseases associated with alterations of the immunological system.

In addition to its pharmaceutical activities in the field of ethical drugs, Italfarmaco also markets generic drugs through the company Lifepharma.

This business is mainly aimed at foreign markets, on some of which Lifepharma has its own offices and sales networks, as in the case of Russia.

In addition to research, production and marketing of drugs, the Italfarmaco Group manufactures active ingredients for the pharmaceutical industry through its subsidiary "Chemi S.p.A."
Chemi S.p.A. sells some 90% of its products on foreign markets (USA, Japan, EU, etc.), on which it collaborates with many international pharmaceutical companies.

Chemi S.p.A. is among the leading manufacturers of active ingredients, and owns advanced technologies in the field of phospholipids, peptides and the chemistry of chiral products.